The Sarcopenia Treatment Market region analysis reveals substantial geographic disparities in disease prevalence, diagnostic capabilities, treatment availability, and healthcare resource allocation for managing age-related muscle loss. North America currently represents the largest regional market, driven by advanced healthcare infrastructure, high disease awareness among...